Stay updated on AK102 in HeFH: PCSK9 Inhibitor Clinical Trial
Sign up to get notified when there's something new on the AK102 in HeFH: PCSK9 Inhibitor Clinical Trial page.

Latest updates to the AK102 in HeFH: PCSK9 Inhibitor Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added; older notices about funding lapse and operating status were removed.SummaryDifference0.9%

- Check21 days agoChange DetectedThe page history adds a government funding notice and updates the revision to v3.4.1, replacing v3.4.0. These are administrative updates rather than changes to the study data, and to avoid being alerted by small changes you can set an alert condition by clicking below.SummaryDifference0.9%

- Check28 days agoChange DetectedThe history page now includes a Show glossary option and legends for green (additions) and red (deletions) highlights, with updated revision notes (Revision: v3.4.0). No substantive study data changes are present.SummaryDifference1%

- Check42 days agoChange DetectedA new revision entry v3.3.4 was added to the record history, replacing v3.3.3, with no impact on the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.3.3 was added and references to HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check92 days agoChange DetectedThe changes are updates to the record history (Revision: v3.3.2 and v3.2.0) affecting only page metadata. They do not modify study details such as eligibility, outcomes, or recruitment; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to AK102 in HeFH: PCSK9 Inhibitor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK102 in HeFH: PCSK9 Inhibitor Clinical Trial page.